[Lung function in the German National Cohort: methods and initial results].
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Karrasch, StefanPeters, Annette
Meisinger, Christa
Ferland, Maike
Jaeschke, Lina
Pischon, Tobias
Fricke, Julia
Keil, Thomas
Gastell, Sylvia
Schulze, Matthias
Brandes, Mirko
Günther, Kathrin
Kuß, Oliver
Schikowski, Tamara
Emmel, Carina
Jöckel, Karl-Heinz
Michels, Karin B
Franzke, Claus-Werner
Langer, Susan
Mikolajczyk, Rafael
Jagodzinski, Annika
Becher, Heiko
Castell, Stefanie
Kemmling, Yvonne
Waniek, Sabina
Lieb, Wolfgang
Wirkner, Kerstin
Loeffler, Markus
Greiser, Karin Halina
Kaaks, Rudolf
Legath, Nicole
Berger, Klaus
Schipf, Sabine
Hoffmann, Wolfgang
Sedlmeier, Anja
Leitzmann, Michael
Brenner, Hermann
Holleczek, Bernd
Schulz, Holger
Issue Date
2020-03-01
Metadata
Show full item recordAbstract
In the present dataset (n = 101,734), spirometry was available for 86,893 study participants and FeNO was available for 15,228 participants. The average (±SD) FEV1 Z score (according to GLI 2012) was -0.321 ± 1.047, the FVC Z score was -0.153 ± 0.941, and the FEV1/FVC Z score was -0.337 ± 0.901. The difference in FEV1/FVC between current smokers and never-smokers increased with age. The average FeNO was 14.2 ÷ 2.0 ppb. Current smoking reduced FeNO levels by 43%, whereas respiratory allergy increased FeNO levels by 16% in nonsmokers.Citation
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Mar;63(3):322-331. doi: 10.1007/s00103-020-03102-1.Affiliation
HZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.Publisher
Springer Open choicePubMed ID
32078705Type
ArticleLanguage
enISSN
1437-1588ae974a485f413a2113503eed53cd6c53
10.1007/s00103-020-03102-1
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
Related articles
- Spirometry-Adjusted Fraction of Exhaled Nitric Oxide Allows Asthma Diagnosis in Children, Adolescents, and Young Adults.
- Authors: Grzelewski T, Stelmach W, Stelmach R, Janas A, Grzelewska A, Witkowski K, Makandjou-Ola E, Majak P, Stelmach I
- Issue date: 2016 Feb
- Reference values of fractional excretion of exhaled nitric oxide among non-smokers and current smokers.
- Authors: Torén K, Murgia N, Schiöler L, Bake B, Olin AC
- Issue date: 2017 Aug 25
- [Effects and significance of methacholine bronchial provocation tests and salbutamol bronchial dilation test on measurements of fractional exhaled nitric oxide in patients with asthma].
- Authors: Liu J, Yu H, Tan X, Wu S, Zhang P, Fang Z, Wang C, He X
- Issue date: 2016 Mar
- Ability of Exhaled Nitric Oxide to Discriminate for Airflow Obstruction Among Frequent Exacerbators of Clinically Diagnosed Asthma.
- Authors: Jalota L, Allison DR, Prajapati V, Vempilly JJ, Jain VV
- Issue date: 2018 Aug
- Prevalence of high fractional exhaled nitric oxide among US youth with asthma.
- Authors: Nguyen DT, Kit BK, Brody D, Akinbami LJ
- Issue date: 2017 Jun